These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
94 related items for PubMed ID: 1335941
1. VIP inhibits CCK-induced gallbladder contraction involving a beta-adrenoceptor mediated pathway in the rainbow trout, Oncorhynchus mykiss, in vivo. Aldman G, Holmgren S. Gen Comp Endocrinol; 1992 Nov; 88(2):287-91. PubMed ID: 1335941 [Abstract] [Full Text] [Related]
2. Efffect of vasoactive intestinal polypeptide on gallbladder smooth muscle in vitro. Ryan JP, Ryave S. Am J Physiol; 1978 Jan; 234(1):E44-6. PubMed ID: 623247 [Abstract] [Full Text] [Related]
3. Interactions of vasoactive intestinal polypeptide and cholecystokinin octapeptide on the control of gallbladder contraction. Strah KM, Melendez RL, Pappas TN, Debas HT. Surgery; 1986 Apr; 99(4):469-73. PubMed ID: 3952671 [Abstract] [Full Text] [Related]
7. Regulation of canine gallbladder motility by brain peptides. Lenz HJ, Zimmerman FG, Messmer B. Gastroenterology; 1993 Jun; 104(6):1678-85. PubMed ID: 8500726 [Abstract] [Full Text] [Related]
8. The vagal nerves and peptides in the control of extrahepatic biliary motility. An experimental study in the cat. Dahlstrand C. Acta Physiol Scand Suppl; 1990 Jun; 589():1-52. PubMed ID: 1700577 [Abstract] [Full Text] [Related]
9. Effects of cholecystokinine on the gallbladder motility: interaction with somatostatin and vasoactive intestinal peptide. Milenov K, Rakovska A, Kalfin R. Acta Physiol Pharmacol Bulg; 1995 Jun; 21(3):67-76. PubMed ID: 8868369 [Abstract] [Full Text] [Related]
10. Duodenal acidification and intra-arterial injection of CCK8 increase gallbladder motility in the rainbow trout, Oncorhynchus mykiss. Aldman G, Grove D, Holmgren S. Gen Comp Endocrinol; 1992 Apr; 86(1):20-5. PubMed ID: 1505726 [Abstract] [Full Text] [Related]
11. Actions of VIP, somatostatin, and pancreatic polypeptide on gallbladder tension and CCK-stimulated gallbladder contraction in vitro. Lonovics J, Devitt P, Rayford PL, Thompson JC. Surg Forum; 1979 Apr; 30():407-9. PubMed ID: 538649 [No Abstract] [Full Text] [Related]
12. The effect of vasoactive intestinal polypeptide (VIP) on the canine gallbladder motility. Kalfin R, Milenov K. Comp Biochem Physiol C Comp Pharmacol Toxicol; 1991 Apr; 100(3):513-7. PubMed ID: 1687549 [Abstract] [Full Text] [Related]
13. Effects of intravenous vasoactive intestinal peptide (VIP) on gallbladder function in the cat. Jansson R, Steen G, Svanvik J. Gastroenterology; 1978 Jul; 75(1):47-50. PubMed ID: 401095 [Abstract] [Full Text] [Related]
14. Characterization of cholecystokinin receptors on the human gallbladder. Tokunaga Y, Cox KL, Coleman R, Concepcion W, Nakazato P, Esquivel CO. Surgery; 1993 Feb; 113(2):155-62. PubMed ID: 7679224 [Abstract] [Full Text] [Related]
15. Mechanisms of action of cholecystokinin in the canine gastrointestinal tract: role of vasoactive intestinal peptide and nitric oxide. Vergara P, Woskowska Z, Cipris S, Fox-Threlkeld JE, Daniel EE. J Pharmacol Exp Ther; 1996 Oct; 279(1):306-16. PubMed ID: 8859008 [Abstract] [Full Text] [Related]
18. Postprandial release of cholecystokinin and pancreatic polypeptide in health and in gallstone disease: relationships with gallbladder contraction. Glasbrenner B, Domínguez-Muñoz JE, Nelson DK, Pieramico O, Holzwarth C, Riepl RL, Malfertheiner P. Am J Gastroenterol; 1994 Mar; 89(3):404-10. PubMed ID: 8122654 [Abstract] [Full Text] [Related]